{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:11:09Z","timestamp":1759947069600,"version":"build-2065373602"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009409","name":"Russian Science Support Foundation","doi-asserted-by":"publisher","award":["24-25-20164"],"award-info":[{"award-number":["24-25-20164"]}],"id":[{"id":"10.13039\/100009409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Modeling cancer recurrence and associated conditions such as cancer cell dormancy remains a significant challenge in cancer research. We developed a novel <jats:italic>in vitro<\/jats:italic> model based on platinum-resistant tumor cells treated with a platinum drug, in which cells progress through all stages of recurrence within 30\u201340 days post-exposure. Our results demonstrate that treatment of platinum-resistant colorectal cancer cells with oxaliplatin enriches the population with quiescent, dormant cells arrested in the G0\/G1 phase. These cells exhibit increased autophagy, elevated expression of stem cell markers, reduced reactive oxygen species (ROS) levels, and heightened resistance to chemotherapy. A key advantage of our model is the high survival rate of residual cells, enabling the maintenance of a large cell population. This facilitates the application of conventional research techniques that are often limited in other recurrence models due to the small size of residual populations. Overall, this model provides opportunities for a wide range of further research for studying specific recurrence- and dormancy-associated signaling pathways and for identifying novel therapeutic targets for preventing tumor recurrence.<\/jats:p>","DOI":"10.1371\/journal.pone.0333671","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:28:39Z","timestamp":1759944519000},"page":"e0333671","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8545-6052","authenticated-orcid":true,"given":"Alisa","family":"Morshneva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2650-4568","authenticated-orcid":true,"given":"Olga","family":"Gnedina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Igotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"1","key":"pone.0333671.ref001","first-page":"197","article-title":"Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution","volume":"42","author":"F Francescangeli","year":"2023","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"pone.0333671.ref002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-023-10096-0","article-title":"Tumor dormancy and disease recurrence","volume":"42","author":"JL Kirkland","year":"2023","journal-title":"Cancer Metastasis Rev"},{"key":"pone.0333671.ref003","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.4161\/cc.5.16.3165","article-title":"The Problem of Cancer Dormancy","volume":"5","author":"JA Aguirre-Ghiso","year":"2006","journal-title":"Cell Cycle"},{"key":"pone.0333671.ref004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.breast.2019.03.001","article-title":"Tumor dormancy at bedside: A late awakening","volume":"45","author":"R Demicheli","year":"2019","journal-title":"Breast"},{"issue":"1","key":"pone.0333671.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.03.048","article-title":"Side population cells in human cancers","volume":"268","author":"C Wu","year":"2008","journal-title":"Cancer Lett"},{"key":"pone.0333671.ref006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13036-018-0120-9","article-title":"Engineered In Vitro Models of Tumor Dormancy and Reactivation","volume":"12","author":"S Pradhan","year":"2018","journal-title":"J Biol Eng"},{"key":"pone.0333671.ref007","first-page":"12","article-title":"In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform","volume":"4","author":"ME Katt","year":"2016","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"pone.0333671.ref008","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"C Zhang","year":"2022","journal-title":"Theranostics"},{"key":"pone.0333671.ref009","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"S Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"pone.0333671.ref010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2007.12.033","article-title":"Visualizing spatiotemporal dynamics of multicellular cell-cycle progression","volume":"132","author":"A Sakaue-Sawano","year":"2008","journal-title":"Cell"},{"issue":"7","key":"pone.0333671.ref011","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"J Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"6","key":"pone.0333671.ref012","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1134\/S1990519X22060037","article-title":"Establishment and Characterization of Human Colon-Cancer Cells Resistant to Cisplatin","volume":"16","author":"AV Morshneva","year":"2022","journal-title":"Cell Tiss Biol"},{"key":"pone.0333671.ref013","doi-asserted-by":"crossref","first-page":"627023","DOI":"10.3389\/fonc.2021.627023","article-title":"Autophagy and Cancer Dormancy","volume":"11","author":"Y Akkoc","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"pone.0333671.ref014","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4143\/crt.2023.468","article-title":"Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies","volume":"55","author":"H-Y Min","year":"2023","journal-title":"Cancer Res Treat"},{"key":"pone.0333671.ref015","first-page":"570","article-title":"Extracellular matrix: a gatekeeper in the transition from dormancy to metastasis","volume":"66","author":"D Barkan","year":"2006","journal-title":"Cancer Research"},{"issue":"18","key":"pone.0333671.ref016","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-10-2574","article-title":"ERK1\/2 and p38\u03b1\/\u03b2 signaling in tumor cell quiescence: opportunities to control dormant residual disease","volume":"17","author":"MS Sosa","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pone.0333671.ref017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.gendis.2022.11.025","article-title":"Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance","volume":"11","author":"EH Maleki","year":"2024","journal-title":"Genes Dis"},{"issue":"10","key":"pone.0333671.ref018","doi-asserted-by":"crossref","DOI":"10.1242\/bio.037374","article-title":"Survivin inhibits excessive autophagy in cancer cells but does so independently of its interaction with LC3","volume":"7","author":"NJ Humphry","year":"2018","journal-title":"Biol Open"},{"key":"pone.0333671.ref019","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial Mesenchymal Transition in Tumor Metastasis","volume":"13","author":"V Mittal","year":"2018","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"pone.0333671.ref020","doi-asserted-by":"crossref","DOI":"10.1002\/dvg.23552","article-title":"Tumor dormancy: EMT beyond invasion and metastasis","volume":"62","author":"P Aouad","year":"2024","journal-title":"Genesis"},{"key":"pone.0333671.ref021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-016-0502-x","article-title":"Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications","volume":"15","author":"SJ Serrano-Gomez","year":"2016","journal-title":"Mol Cancer"},{"issue":"6","key":"pone.0333671.ref022","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","article-title":"Epithelial-Mesenchymal Transition in Cancer: A Historical Overview","volume":"13","author":"D Ribatti","year":"2020","journal-title":"Transl Oncol"},{"issue":"10","key":"pone.0333671.ref023","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"TT Onder","year":"2008","journal-title":"Cancer Res"},{"issue":"3","key":"pone.0333671.ref024","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/cells9030623","article-title":"Hybrid Epithelial\/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms","volume":"9","author":"T-T Liao","year":"2020","journal-title":"Cells"},{"issue":"1809","key":"pone.0333671.ref025","doi-asserted-by":"crossref","first-page":"20200087","DOI":"10.1098\/rstb.2020.0087","article-title":"Epithelial-mesenchymal plasticity: emerging parallels between tissue morphogenesis and cancer metastasis","volume":"375","author":"AT Plygawko","year":"2020","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"pone.0333671.ref026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12964-015-0106-x","article-title":"Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines","volume":"13","author":"J Cursons","year":"2015","journal-title":"Cell Commun Signal"},{"key":"pone.0333671.ref027","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fonc.2018.00381","article-title":"EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?","volume":"8","author":"K Weidenfeld","year":"2018","journal-title":"Front Oncol"},{"key":"pone.0333671.ref028","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2018.12.002","article-title":"Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting","volume":"141","author":"S Talukdar","year":"2019","journal-title":"Adv Cancer Res"},{"issue":"1","key":"pone.0333671.ref029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085419","article-title":"CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming","volume":"9","author":"RH Quintanilla","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"pone.0333671.ref030","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3390\/cells10102707","article-title":"Redox Control of the Dormant Cancer Cell Life Cycle","volume":"10","author":"B Li","year":"2021","journal-title":"Cells"},{"issue":"3","key":"pone.0333671.ref031","doi-asserted-by":"crossref","first-page":"979","DOI":"10.62347\/XTRT2780","article-title":"Novel chromium (III)-based compound for inhibition of oxaliplatin-resistant colorectal cancer progression","volume":"14","author":"M-C Chen","year":"2024","journal-title":"Am J Cancer Res"},{"issue":"7","key":"pone.0333671.ref032","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1002\/jcp.26406","article-title":"Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis","volume":"233","author":"H-H Hsu","year":"2018","journal-title":"J Cell Physiol"},{"issue":"45","key":"pone.0333671.ref033","doi-asserted-by":"crossref","first-page":"78466","DOI":"10.18632\/oncotarget.19638","article-title":"Characterization and functional analysis of a slow-cycling subpopulation in colorectal cancer enriched by cell cycle inducer combined chemotherapy","volume":"8","author":"F-H Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"pone.0333671.ref034","article-title":"Model of tumor dormancy\/recurrence after short-term chemotherapy","volume":"9","author":"S Li","year":"2014","journal-title":"PLoS One"},{"issue":"24","key":"pone.0333671.ref035","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.3390\/cancers16244273","article-title":"Disrupted Lipid Metabolism, Cytokine Signaling, and Dormancy: Hallmarks of Doxorubicin-Resistant Triple-Negative Breast Cancer Models","volume":"16","author":"R Vishnubalaji","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"pone.0333671.ref036","article-title":"Investigating breast cancer cell behavior using tissue engineering scaffolds","volume":"10","author":"K Guiro","year":"2015","journal-title":"PLoS One"},{"issue":"7679","key":"pone.0333671.ref037","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"MJ Hangauer","year":"2017","journal-title":"Nature"},{"issue":"9","key":"pone.0333671.ref038","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3390\/cancers12092655","article-title":"FUCCI Real-Time Cell-Cycle Imaging as a Guide for Designing Improved Cancer Therapy: A Review of Innovative Strategies to Target Quiescent Chemo-Resistant Cancer Cells","volume":"12","author":"S Yano","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"20","key":"pone.0333671.ref039","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1158\/0008-5472.CAN-04-0113","article-title":"Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth","volume":"64","author":"JA Aguirre-Ghiso","year":"2004","journal-title":"Cancer Res"},{"key":"pone.0333671.ref040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4161\/cbt.5.7.2968","article-title":"Tumor Cell Dormancy Induced by p38SAPK and ER-Stress Signaling","volume":"5","author":"AC Ranganathan","year":"2006","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"pone.0333671.ref041","doi-asserted-by":"crossref","first-page":"745","DOI":"10.21873\/anticanres.15533","article-title":"Exosomal p38 Mitogen-activated Protein Kinase Promotes Tumour Repopulation in TP53-mutated Bile Duct Cancer Cells","volume":"42","author":"M Osawa","year":"2022","journal-title":"Anticancer Res"},{"issue":"2","key":"pone.0333671.ref042","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbrc.2009.02.156","article-title":"Embryonic stem cell markers expression in cancers","volume":"383","author":"M Schoenhals","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"pone.0333671.ref043","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/ijms24032400","article-title":"The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression-ALDH1A1, CD133, CD44-For Survival and Long-Term Follow-Up of Ovarian Cancer Patients","volume":"24","author":"N Izycka","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0333671.ref044","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65418","article-title":"Association of human breast cancer CD44-\/CD24- cells with delayed distant metastasis","volume":"10","author":"X Qiao","year":"2021","journal-title":"Elife"},{"issue":"9","key":"pone.0333671.ref045","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.3390\/ijms23094922","article-title":"CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status","volume":"23","author":"M Pustovalova","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0333671.ref046","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41375-024-02473-7","article-title":"High CD44 expression and enhanced E-selectin binding identified as biomarkers of chemoresistant leukemic cells in human T-ALL","volume":"39","author":"J Calvo","year":"2024","journal-title":"Leukemia"},{"key":"pone.0333671.ref047","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcancer.2021.04.021","article-title":"Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis","volume":"78","author":"S Basu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"pone.0333671.ref048","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1479-5876-9-209","article-title":"Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy","volume":"9","author":"PV Pham","year":"2011","journal-title":"J Transl Med"},{"issue":"2","key":"pone.0333671.ref049","doi-asserted-by":"crossref","first-page":"188500","DOI":"10.1016\/j.bbcan.2020.188500","article-title":"Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy","volume":"1875","author":"PP Praharaj","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"pone.0333671.ref050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10585-022-10146-x","article-title":"Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis","volume":"39","author":"M Primeaux","year":"2022","journal-title":"Clin Exp Metastasis"},{"issue":"20","key":"pone.0333671.ref051","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1158\/0008-5472.CAN-12-0254","article-title":"Clusterin mediates TGF-\u03b2-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells","volume":"72","author":"M Shiota","year":"2012","journal-title":"Cancer Res"},{"issue":"6","key":"pone.0333671.ref052","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156057","article-title":"Stabilization of E-cadherin adhesions by COX-2\/GSK3\u03b2 signaling is a targetable pathway in metastatic breast cancer","volume":"8","author":"K Balamurugan","year":"2023","journal-title":"JCI Insight"},{"issue":"2","key":"pone.0333671.ref053","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2018.07.001","article-title":"Hybrid epithelial\/mesenchymal phenotype(s): The \u201cfittest\u201d for metastasis?","volume":"1870","author":"MK Jolly","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"11","key":"pone.0333671.ref054","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3390\/biom10111561","article-title":"Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression","volume":"10","author":"D Sinha","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"pone.0333671.ref055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13058-021-01416-9","article-title":"Cellular dormancy in minimal residual disease following targeted therapy","volume":"23","author":"JR Ruth","year":"2021","journal-title":"Breast Cancer Res"},{"key":"pone.0333671.ref056","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fmolb.2020.00138","article-title":"Slug and E-Cadherin: Stealth Accomplices?","volume":"7","author":"E Sterneck","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"10","key":"pone.0333671.ref057","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/jcb.25972","article-title":"Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic Hypoxia","volume":"118","author":"A Carcereri de Prati","year":"2017","journal-title":"J Cell Biochem"},{"key":"pone.0333671.ref058","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.redox.2015.06.019","article-title":"Redox regulation of FoxO transcription factors","volume":"6","author":"L-O Klotz","year":"2015","journal-title":"Redox Biol"},{"issue":"23","key":"pone.0333671.ref059","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.3390\/cancers14235857","article-title":"Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer","volume":"14","author":"M Muzza","year":"2022","journal-title":"Cancers (Basel)"},{"key":"pone.0333671.ref060","doi-asserted-by":"crossref","first-page":"111008","DOI":"10.1016\/j.cellsig.2023.111008","article-title":"NOX4 alleviates breast cancer cell aggressiveness by co-ordinating mitochondrial turnover through PGC1\u03b1\/Drp1 axis","volume":"115","author":"D Bhadane","year":"2024","journal-title":"Cell Signal"},{"key":"pone.0333671.ref061","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2013.12.007","article-title":"The role of reactive oxygen species and metabolism on cancer cells and their microenvironment","volume":"25","author":"A Costa","year":"2014","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"pone.0333671.ref062","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1158\/1541-7786.MCR-11-0033","article-title":"Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinase","volume":"9","author":"H-L Nguyen","year":"2011","journal-title":"Mol Cancer Res"},{"issue":"1","key":"pone.0333671.ref063","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","article-title":"Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance","volume":"12","author":"H Huang","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"pone.0333671.ref064","first-page":"1765","article-title":"Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells","volume":"39","author":"S Keeratichamroen","year":"2018","journal-title":"Oncol Rep"},{"key":"pone.0333671.ref065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12967-016-0798-8","article-title":"From competency to dormancy: a 3D model to study cancer cells and drug responsiveness","volume":"14","author":"JY Fang","year":"2016","journal-title":"J Transl Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:28:51Z","timestamp":1759944531000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333671"}},"subtitle":[],"editor":[{"given":"Li","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":65,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0333671","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}